New drug combo aims to tackle tough lymphoma
Disease control
Not yet recruiting
This study tests a combination of two drugs, loncastuximab tesirine and epcoritamab, in people with aggressive B-cell lymphoma that has come back or not responded to treatment. The goal is to see if the combination can shrink or eliminate the cancer. About 120 adults who have alr…
Phase: PHASE2 • Sponsor: Universität Münster • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC